title: NSAID and oesophageal adenocarcinoma: randomised trials needed to correct for bias.
authors.forename: Janusz
authors.initials: J
authors.lastname: Jankowski
authors.forename: John
authors.initials: J
authors.lastname: deCaestecker
authors.forename: Rebecca
authors.initials: R
authors.lastname: Harrison
authors.forename: Peter
authors.initials: P
authors.lastname: Watson
authors.forename: Hugh
authors.initials: H
authors.lastname: Barr
authors.forename: Stephen
authors.initials: S
authors.lastname: Attwood
authors.forename: Paul
authors.initials: P
authors.lastname: Moayyedi
mesh_terms: D000230:Adenocarcinoma / Q000209:etiology / Q000517:prevention & control*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001471:Barrett Esophagus / Q000150:complications* / Q000188:drug therapy; D004938:Esophageal Neoplasms / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D015203:Reproducibility of Results; D012107:Research Design; D012307:Risk Factors; D013534:Survival
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal